🇪🇺 TMX-101 in European Union

EMA authorised TMX-101 on 18 September 1998

Marketing authorisation

EMA — authorised 18 September 1998

  • Application: EMEA/H/C/000180
  • Marketing authorisation holder: Laboratoires 3M Santé
  • Local brand name: Zartra
  • Indication: Imiquimod cream is indicated for the topical treatment of external genital and perianal warts (condyloma acuminata) in adult patients.
  • Status: withdrawn

Read official source →

Frequently asked questions

Is TMX-101 approved in European Union?

Yes. EMA authorised it on 18 September 1998.

Who is the marketing authorisation holder for TMX-101 in European Union?

Laboratoires 3M Santé holds the EU marketing authorisation.